Australian medical research investment fund signs up Kiwis 26 Jul 2016
Related articles
- All Whites claim historic point Sport
- Prime Minister to travel to South Africa News
- Brownlee Leads Aviation Mission To Shanghai News
- New Zealand-Russia begin FTA scoping discussions News
- NZ looking at all avenues on whaling issue News
- Sludge Report #192: The Naked Budget Columns
- Budget provides $321m for RS&T activities News
- Licensing To Cut Out Cowboy Advisers Migration
- Government Widens Drought Assistance News
- 300 feet down: two bare feet and one breath of air Living
Australian medical research investment fund signs up Kiwi members
By Fiona Rotherham
July 26 (BusinessDesk) - Three New Zealand research organisations have signed up to become members of the Medical Research Commercialisation Fund, Australia’s largest life science venture fund.
Otago University, the Malaghan Institute, and Callaghan Innovation are joining the fund’s collaborative structure which includes more than 50 Australian medical research institutes and research hospitals, the Australian federal government and five state governments. The A$200 million fund managed by Australian venture capital firm Brandon Capital includes backing from four of Australia’s largest industry superannuation funds – AustralianSuper, HESTA, Statewide Super, and Hostplus.
Since 2007, the firm has already fully invested two other smaller funds and supported the development of 27 start-ups developing biotech or medical device technologies originating from members. A couple of investment successes include Spinifex Pharmaceuticals which was sold last year to Novartis for US$725 million and Fibrotech Therapeutics which netted US$557 million when sold to Shire in 2014.
In February the New Zealand government paid A$500,000 to become a member, the same amount as Australian states. That paved the way for other New Zealand members to join and their research to be considered for investment by the third fund.
Brandon Capital’s new New Zealand investment manager Duncan Mackintosh was most recently chief executive of Waikatolink, the University of Waikato’s commercial arm. He said Brandon’s previous life science funds didn’t allow for investment outside Australia whereas this one has added New Zealand in like “another state”.
“The MRCF funding helps promising technologies bridge the current market failure, the so-called ‘Valley of Death’, enabling them to progress beyond grant funding to a point where they have achieved clinical or prototype proof of concept and/or market validation.”
Brandon managing director Chris Nave said New Zealand ranks highly in terms of its medical innovations internationally and the latest fund had the capacity to support the best research opportunities from across Australasia. Around A$50 million of the fund will go to seed investment and the remainder is reserved to support the most promising of these and existing portfolio companies through to mid-stage clinical trials.
Early stage opportunities can receive up to A$3 million to support preclinical development, with those progressing to the next stage able to receive a further A$17 million, and that can stretch to A$30 million. The superannuation investors can also individually invest as the start-ups mature.
The fund has first right to invest in discoveries from its hospital and university research partners. In exchange, the partners get a small share of any profits from successful commercialisations which incentivises them to help competitors succeed.
Pete Hodgson, chief executive of Otago University’s commercialisation arm Otago Innovation, said it was an obvious choice to sign up even though the university understood deal flow is always dependent on the quality of the science and that it’s a numbers game.
“Over the course of the next year or so Otago University IP is sufficiently deep that we anticipate one or more investment opportunities,” he said. “These guys are strong and have a longer track record than anyone in New Zealand.”
The fund runs an investment committee, similar to Auckland University’s Return on Science, which members can attend and the best research ideas submitted for funding are considered. Mackintosh said it can take up to six months from a project being put forward to a final funding decision, given the number of competing projects and the return thresholds required.
Key investment considerations include whether it is world-class science, a significant breakthrough in its field, the potential market size and need, competition, and the strength of the intellectual property.
It has proven difficult in New Zealand to access the capital required to commercialise this type of “high-risk, high-reward projects that require a well-funded investor”, said Mike Zablocki, chief operating officer for the Malaghan Institute. The medical research institute is focused on finding cures for cancer, asthma and allergy, multiple sclerosis, and infectious diseases and Zablocki said it has some IP worth trying to develop.
A key advantage to membership was the opportunity to network and assess the capability of the Australian members regularly as he said it’s “not that easy getting that many of them in the same room at once”.
Callaghan Innovation national technology network manager for biotech, Kim Jordan, said membership acts as a bridge to the fund for client companies and to become part of a larger Australasian network focused on creating wealth and high-value jobs from life science technology.
“It will also give Callaghan Innovation visibility over focused, specialised, and deeply experienced biomedical venture assessment, development and management skills that are not readily available in New Zealand,” she said.
(BusinessDesk receives some assistance from Callaghan to cover the commercialisation of innovation)
(BusinessDesk)
News
Hilary Timmins' Award-Winning UK Documentary Series To Inspire NZ Students
29 Jun 2020 Education
Dream Catchers, produced and directed by Hilary Timmins, celebrates the success stories of more than thirty inspirational New... more
New Zealand reaffirms support for Flight MH17 judicial process
7 Mar 2020 News
Ahead of the start of the criminal trial in the Netherlands on 9 March, Foreign Minister Winston Peters has reaffirmed the need to... more
Business
NZ Government's Economic package to fight COVID-19
17 Mar 2020 Business News
The Coalition Government has launched the most significant peace-time economic plan in modern New Zealand history to cushion the... more
NZ Government announces aviation relief package
19 Mar 2020 Business News
Transport Minister Phil Twyford today outlined the first tranche of the $600 million aviation sector relief package announced earlier... more
Living
Diversity was Key at New Zealand Trade Tasting in London
6 Jun 2022 Food & Wine
New Zealand Winegrowers Annual Trade Tasting was recently held in London, on Wednesday 4 May, in Lindley Hall.
It was the first... more
Kiwi author stuns Behind the Butterfly Gate
12 Jan 2022 Arts
Hidden behind the Butterfly Gate is where the secret has been kept for 76 years...
New Zealand writer Merryn Corcoran’s... more
Property
Fairer rules for tenants and landlords
17 Nov 2019 Property
17 NOVEMBER 2019
The Government has delivered on its promise to the over one million New Zealanders who now rent to make it fairer... more
New Zealand Government will not implement a Capital Gains Tax
17 Apr 2019 Property
The Coalition Government will not proceed with the Tax Working Group’s recommendation for a capital gains tax, Jacinda Ardern... more
Migration
Boosting border security with electronic travel authority – now over 500,000 issued
19 Nov 2019 Migration
19 NOVEMBER 2019
We’ve improved border security with the NZeTA, New Zealand Electronic Travel Authority, which helps us to... more
Christchurch reinstated as refugee settlement location
18 Aug 2018 Migration
18 AUGUST 2018
HON IAIN LEES-GALLOWAY
The announcement that Christchurch can once again be a settlement location for refugees... more
Travel
Gallipoli Anzac Day services cancelled
19 Mar 2020 Travel & Tourism
The New Zealand and Australian Governments have announced this year’s joint Anzac Day services at Gallipoli will be cancelled... more
New Zealanders advised not to travel overseas
19 Mar 2020 Travel & Tourism
New Zealanders advised not to travel overseas
more
Sport
The Skipper's Diary: Sir Richard Hadlee honouring his father and NZ's Forty-Niners
27 Oct 2019 Cricket
NZNewsUK London Editor Charlotte Everett spoke to Sir Richard Hadlee about why he’s chosen to publish his father’s... more
PREVIEW: All Blacks v England semi-final
26 Oct 2019 Rugby
The two most convincing quarterfinals winners are set to square off in a semifinal showdown for the ages when the All Blacks meet old... more
Columns
Gordon Campbell on the Gareth Morgan crusade
11 Nov 2016 Opinion
Gordon Campbell on the Gareth Morgan crusade
First published on Werewolf
The ghastly likes of Marine Le Pen in France and Geert ... more
Gordon Campbell on the US election outcome
10 Nov 2016 Opinion
Column - Gordon Campbell
Gordon Campbell on the US election outcome
Well um.. on the bright side, there (probably)... more
Kiwi Success
Congratulations to Loder Cup winner
26 Sep 2018 People
25 SEPTEMBER 2018
The Loder Cup, one of New Zealand’s oldest conservation awards, has been awarded to Robert McGowan for 2018... more
Appointments to New Zealand National Commission for UNESCO
16 Aug 2018 Appointments
16 AUGUST 2018Appointments to New Zealand National Commission for UNESCO
HON JENNY SALESA
Associate Education Minister Jenny Salesa is... more
Recruitment
Historic pay equity settlement for education support workers
14 Aug 2018 Recruitment
14 AUGUST 2018Historic pay equity settlement for education support workers
RT HON JACINDA ARDERN
HON CHRIS HIPKINS
Prime Minister
The... more
Historic pay equity settlement for education support workers
22 Aug 2018 Recruitment
14 AUGUST 2018Historic pay equity settlement for education support workers
RT HON JACINDA ARDERN
HON CHRIS HIPKINS
Prime Minister
The... more